| 0 |
CUTANEOUS EXTRAMEDULLARY HAEMOPOIESIS |
1 |
0.1667 |
| 1 |
MULTISYSTEM INFLAMMATORY SYNDROME IN ADULTS |
1 |
0.0556 |
| 2 |
NEONATAL CANDIDA INFECTION |
1 |
0.0233 |
| 3 |
NEURONE-SPECIFIC ENOLASE INCREASED |
1 |
0.0233 |
| 4 |
EYE INFARCTION |
1 |
0.0100 |
| 5 |
CONGENITAL ANOMALY IN OFFSPRING |
1 |
0.0076 |
| 6 |
PRODUCT WITH QUALITY ISSUE ADMINISTERED |
3 |
0.0067 |
| 7 |
MICROSPORIDIA INFECTION |
2 |
0.0057 |
| 8 |
TOXIC SHOCK SYNDROME STREPTOCOCCAL |
1 |
0.0052 |
| 9 |
FACTOR V INHIBITION |
1 |
0.0052 |
| 10 |
GASTROSTOMY TUBE SITE COMPLICATION |
1 |
0.0050 |
| 11 |
DYSBACTERIOSIS |
1 |
0.0047 |
| 12 |
AUTOIMMUNE NEUTROPENIA |
1 |
0.0035 |
| 13 |
SPUTUM PURULENT |
2 |
0.0030 |
| 14 |
SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA |
2 |
0.0024 |
| 15 |
FEEDING INTOLERANCE |
1 |
0.0022 |
| 16 |
BURNING MOUTH SYNDROME |
1 |
0.0018 |
| 17 |
PNEUMOCYSTIS JIROVECII INFECTION |
2 |
0.0017 |
| 18 |
TOXIC SHOCK SYNDROME |
1 |
0.0016 |
| 19 |
SJS-TEN OVERLAP |
1 |
0.0014 |
| 20 |
PELVIC FLUID COLLECTION |
1 |
0.0014 |
| 21 |
GLOMERULONEPHRITIS MINIMAL LESION |
1 |
0.0014 |
| 22 |
PRODUCT ODOUR ABNORMAL |
14 |
0.0013 |
| 23 |
KOUNIS SYNDROME |
3 |
0.0013 |
| 24 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
10 |
0.0013 |
| 25 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
3 |
0.0011 |
| 26 |
SKIN TEST POSITIVE |
1 |
0.0011 |
| 27 |
PYURIA |
1 |
0.0010 |
| 28 |
RETINAL TOXICITY |
1 |
0.0010 |
| 29 |
CLOSTRIDIUM TEST POSITIVE |
2 |
0.0009 |
| 30 |
VANISHING BILE DUCT SYNDROME |
1 |
0.0009 |
| 31 |
KLEBSIELLA SEPSIS |
1 |
0.0009 |
| 32 |
CATHETER RELATED COMPLICATION |
1 |
0.0009 |
| 33 |
PRODUCT TASTE ABNORMAL |
12 |
0.0009 |
| 34 |
CHRONIC RESPIRATORY FAILURE |
1 |
0.0008 |
| 35 |
XEROSIS |
1 |
0.0008 |
| 36 |
BETA HAEMOLYTIC STREPTOCOCCAL INFECTION |
1 |
0.0008 |
| 37 |
RETINAL DEGENERATION |
1 |
0.0008 |
| 38 |
HYPERSENSITIVITY VASCULITIS |
2 |
0.0008 |
| 39 |
MACULAR HOLE |
1 |
0.0007 |
| 40 |
PNEUMATOSIS INTESTINALIS |
2 |
0.0007 |
| 41 |
COMA SCALE ABNORMAL |
2 |
0.0007 |
| 42 |
LIQUID PRODUCT PHYSICAL ISSUE |
5 |
0.0007 |
| 43 |
MEGACOLON |
1 |
0.0006 |
| 44 |
INAPPROPRIATE AFFECT |
1 |
0.0006 |
| 45 |
ENTEROCOCCAL INFECTION |
3 |
0.0006 |
| 46 |
CONTRAINDICATED PRODUCT PRESCRIBED |
1 |
0.0006 |
| 47 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
2 |
0.0006 |
| 48 |
INCORRECT STORAGE OF DRUG |
1 |
0.0006 |
| 49 |
ORGAN FAILURE |
2 |
0.0005 |
| 50 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
12 |
0.0005 |
| 51 |
STAPHYLOCOCCAL BACTERAEMIA |
2 |
0.0005 |
| 52 |
CHOLESTATIC LIVER INJURY |
1 |
0.0004 |
| 53 |
PSEUDOMEMBRANOUS COLITIS |
1 |
0.0004 |
| 54 |
IDIOPATHIC INTRACRANIAL HYPERTENSION |
1 |
0.0004 |
| 55 |
IMMUNE THROMBOCYTOPENIA |
2 |
0.0004 |
| 56 |
METHAEMOGLOBINAEMIA |
1 |
0.0004 |
| 57 |
VOLVULUS |
1 |
0.0004 |
| 58 |
KLEBSIELLA INFECTION |
2 |
0.0004 |
| 59 |
PRODUCT CONTAMINATION PHYSICAL |
1 |
0.0004 |
| 60 |
GASTROINTESTINAL INJURY |
1 |
0.0004 |
| 61 |
GAMBLING DISORDER |
1 |
0.0004 |
| 62 |
SERUM SICKNESS |
1 |
0.0004 |
| 63 |
OESOPHAGEAL STENOSIS |
1 |
0.0004 |
| 64 |
UPPER RESPIRATORY TRACT CONGESTION |
1 |
0.0003 |
| 65 |
NORMOCHROMIC NORMOCYTIC ANAEMIA |
1 |
0.0003 |
| 66 |
EXPOSURE TO TOXIC AGENT |
1 |
0.0003 |
| 67 |
POOR QUALITY DRUG ADMINISTERED |
2 |
0.0003 |
| 68 |
HYPOVENTILATION |
1 |
0.0003 |
| 69 |
CARBOHYDRATE ANTIGEN 125 INCREASED |
1 |
0.0003 |
| 70 |
WOUND COMPLICATION |
1 |
0.0003 |
| 71 |
FIBRIN D DIMER INCREASED |
1 |
0.0003 |
| 72 |
PRODUCT CONTAMINATION |
1 |
0.0003 |
| 73 |
FOOD INTOLERANCE |
1 |
0.0003 |
| 74 |
THROMBOCYTOSIS |
1 |
0.0003 |
| 75 |
OESOPHAGEAL ULCER |
1 |
0.0003 |
| 76 |
POST PROCEDURAL HAEMORRHAGE |
3 |
0.0003 |
| 77 |
ANAPHYLACTOID REACTION |
1 |
0.0002 |
| 78 |
PULSELESS ELECTRICAL ACTIVITY |
1 |
0.0002 |
| 79 |
PSEUDOMONAS INFECTION |
2 |
0.0002 |
| 80 |
CLOSTRIDIUM DIFFICILE INFECTION |
5 |
0.0002 |
| 81 |
LOCALISED OEDEMA |
1 |
0.0002 |
| 82 |
ROSACEA |
1 |
0.0002 |
| 83 |
STAPHYLOCOCCAL SEPSIS |
1 |
0.0002 |
| 84 |
PRODUCT ADMINISTRATION ERROR |
4 |
0.0002 |
| 85 |
DYSPHORIA |
1 |
0.0002 |
| 86 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
1 |
0.0002 |
| 87 |
TOXIC ENCEPHALOPATHY |
1 |
0.0002 |
| 88 |
PRODUCT COLOUR ISSUE |
1 |
0.0002 |
| 89 |
GASTROINTESTINAL MOTILITY DISORDER |
1 |
0.0002 |
| 90 |
CHEILITIS |
1 |
0.0002 |
| 91 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
1 |
0.0002 |
| 92 |
RASH MACULO-PAPULAR |
4 |
0.0002 |
| 93 |
NEPHROPATHY TOXIC |
2 |
0.0002 |
| 94 |
NEUTROPHILIA |
1 |
0.0002 |
| 95 |
EOSINOPHILIA |
3 |
0.0002 |
| 96 |
SEPTIC SHOCK |
7 |
0.0002 |
| 97 |
DRUG RESISTANCE |
4 |
0.0002 |
| 98 |
HUNGER |
2 |
0.0001 |
| 99 |
PAROSMIA |
1 |
0.0001 |
| 100 |
TOXIC EPIDERMAL NECROLYSIS |
2 |
0.0001 |
| 101 |
ATRIOVENTRICULAR BLOCK |
1 |
0.0001 |
| 102 |
TORSADE DE POINTES |
1 |
0.0001 |
| 103 |
PRODUCT USE COMPLAINT |
2 |
0.0001 |
| 104 |
URINE OUTPUT DECREASED |
1 |
0.0001 |
| 105 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
2 |
0.0001 |
| 106 |
DRUG ERUPTION |
2 |
0.0001 |
| 107 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 108 |
HEAVY MENSTRUAL BLEEDING |
1 |
0.0001 |
| 109 |
IRON DEFICIENCY ANAEMIA |
1 |
0.0001 |
| 110 |
ARTERIOSCLEROSIS |
1 |
0.0001 |
| 111 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
3 |
0.0001 |
| 112 |
RENAL TUBULAR NECROSIS |
1 |
0.0001 |
| 113 |
KNEE OPERATION |
1 |
0.0001 |
| 114 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
1 |
0.0001 |
| 115 |
PRODUCT PHYSICAL ISSUE |
2 |
0.0001 |
| 116 |
DRUG-INDUCED LIVER INJURY |
3 |
0.0001 |
| 117 |
POOR QUALITY PRODUCT ADMINISTERED |
1 |
0.0001 |
| 118 |
INCONTINENCE |
1 |
0.0001 |
| 119 |
OESOPHAGITIS |
1 |
0.0001 |
| 120 |
GASTROINTESTINAL PAIN |
1 |
0.0001 |
| 121 |
OBSTRUCTIVE AIRWAYS DISORDER |
1 |
0.0001 |
| 122 |
INTESTINAL PERFORATION |
1 |
0.0001 |
| 123 |
MYOCARDITIS |
1 |
0.0001 |
| 124 |
GASTRIC HAEMORRHAGE |
1 |
0.0001 |
| 125 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 126 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 127 |
PRODUCT STORAGE ERROR |
7 |
0.0001 |
| 128 |
HEPATITIS |
2 |
0.0001 |
| 129 |
NODULE |
1 |
0.0001 |
| 130 |
JAUNDICE |
2 |
0.0001 |
| 131 |
GINGIVAL BLEEDING |
1 |
0.0001 |
| 132 |
BLOOD TEST ABNORMAL |
1 |
0.0001 |
| 133 |
ANGIOEDEMA |
3 |
0.0001 |
| 134 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 135 |
OSTEOPENIA |
1 |
0.0001 |
| 136 |
DELUSION |
1 |
0.0001 |
| 137 |
ACUTE MYELOID LEUKAEMIA |
1 |
0.0001 |
| 138 |
HALLUCINATION, AUDITORY |
1 |
0.0001 |
| 139 |
MULTI-ORGAN FAILURE |
1 |
0.0001 |
| 140 |
ISCHAEMIC STROKE |
1 |
0.0001 |
| 141 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 142 |
OSTEOMYELITIS |
1 |
0.0001 |
| 143 |
ANAPHYLACTIC REACTION |
3 |
0.0001 |
| 144 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 145 |
AGRANULOCYTOSIS |
1 |
0.0001 |
| 146 |
TUBULOINTERSTITIAL NEPHRITIS |
1 |
0.0001 |
| 147 |
INTESTINAL OBSTRUCTION |
2 |
0.0001 |
| 148 |
PRODUCT USE IN UNAPPROVED INDICATION |
13 |
0.0001 |
| 149 |
PYREXIA |
17 |
0.0000 |
| 150 |
TREATMENT FAILURE |
4 |
0.0000 |
| 151 |
HAEMORRHAGE |
5 |
0.0000 |
| 152 |
DERMATITIS |
1 |
0.0000 |
| 153 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 154 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 155 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
0.0000 |
| 156 |
STEVENS-JOHNSON SYNDROME |
1 |
0.0000 |
| 157 |
GLOSSODYNIA |
1 |
0.0000 |
| 158 |
ORAL PAIN |
1 |
0.0000 |
| 159 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 160 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 161 |
LIVER INJURY |
1 |
0.0000 |
| 162 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 163 |
OSTEONECROSIS OF JAW |
1 |
0.0000 |
| 164 |
DYSGEUSIA |
3 |
0.0000 |
| 165 |
AGEUSIA |
1 |
0.0000 |
| 166 |
LEUKOPENIA |
2 |
0.0000 |
| 167 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 168 |
INFLAMMATION |
2 |
0.0000 |
| 169 |
PHARMACEUTICAL PRODUCT COMPLAINT |
1 |
0.0000 |
| 170 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 171 |
BRADYCARDIA |
2 |
0.0000 |
| 172 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 173 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 174 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 175 |
HYPERSOMNIA |
1 |
0.0000 |
| 176 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 177 |
ASCITES |
1 |
0.0000 |
| 178 |
DISEASE PROGRESSION |
4 |
0.0000 |
| 179 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 180 |
HEPATIC FAILURE |
1 |
0.0000 |
| 181 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 182 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 183 |
EYE DISORDER |
1 |
0.0000 |
| 184 |
LIP SWELLING |
1 |
0.0000 |
| 185 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 186 |
CONDITION AGGRAVATED |
9 |
0.0000 |
| 187 |
HAEMATURIA |
1 |
0.0000 |
| 188 |
HYPOXIA |
1 |
0.0000 |
| 189 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 190 |
VOMITING |
13 |
0.0000 |
| 191 |
CRYING |
1 |
0.0000 |
| 192 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 193 |
RESPIRATORY FAILURE |
2 |
0.0000 |
| 194 |
RESTLESSNESS |
1 |
0.0000 |
| 195 |
COLITIS |
1 |
0.0000 |
| 196 |
ACUTE KIDNEY INJURY |
4 |
0.0000 |
| 197 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 198 |
DYSKINESIA |
1 |
0.0000 |
| 199 |
BLINDNESS |
1 |
0.0000 |
| 200 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 201 |
DRUG INEFFECTIVE |
32 |
0.0000 |
| 202 |
URTICARIA |
4 |
0.0000 |
| 203 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 204 |
RENAL FAILURE ACUTE |
1 |
0.0000 |
| 205 |
RECTAL HAEMORRHAGE |
1 |
0.0000 |
| 206 |
DEVICE DISLOCATION |
1 |
0.0000 |
| 207 |
RASH |
10 |
0.0000 |
| 208 |
TACHYCARDIA |
2 |
0.0000 |
| 209 |
MATERNAL EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 210 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 211 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 212 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 213 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 214 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 215 |
HYPERSENSITIVITY |
4 |
0.0000 |
| 216 |
THERAPY CESSATION |
1 |
0.0000 |
| 217 |
PANCREATITIS |
1 |
0.0000 |
| 218 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 219 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 220 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 221 |
SEPSIS |
2 |
0.0000 |
| 222 |
ABDOMINAL DISCOMFORT |
3 |
0.0000 |
| 223 |
BLISTER |
1 |
0.0000 |
| 224 |
ASTHMA |
2 |
0.0000 |
| 225 |
FLATULENCE |
1 |
0.0000 |
| 226 |
HERPES ZOSTER |
1 |
0.0000 |
| 227 |
ABDOMINAL PAIN |
4 |
0.0000 |
| 228 |
SURGERY |
1 |
0.0000 |
| 229 |
DIARRHOEA |
11 |
0.0000 |
| 230 |
NASAL CONGESTION |
1 |
0.0000 |
| 231 |
CHEST PAIN |
3 |
0.0000 |
| 232 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 233 |
PRURITUS |
6 |
0.0000 |
| 234 |
LOSS OF CONSCIOUSNESS |
2 |
0.0000 |
| 235 |
RHINORRHOEA |
1 |
0.0000 |
| 236 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 237 |
SWELLING FACE |
1 |
0.0000 |
| 238 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 239 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 240 |
RENAL FAILURE |
2 |
0.0000 |
| 241 |
ABDOMINAL PAIN UPPER |
3 |
0.0000 |
| 242 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 243 |
AGITATION |
1 |
0.0000 |
| 244 |
PRODUCT DOSE OMISSION ISSUE |
4 |
0.0000 |
| 245 |
EPISTAXIS |
1 |
0.0000 |
| 246 |
DIABETES MELLITUS |
1 |
0.0000 |
| 247 |
NAUSEA |
10 |
0.0000 |
| 248 |
DRUG INTERACTION |
2 |
0.0000 |
| 249 |
FEELING ABNORMAL |
3 |
0.0000 |
| 250 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 251 |
DRY MOUTH |
1 |
0.0000 |
| 252 |
FOETAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 253 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 254 |
MYALGIA |
2 |
0.0000 |
| 255 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 256 |
INSOMNIA |
3 |
0.0000 |
| 257 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |
| 258 |
DYSPNOEA |
6 |
0.0000 |
| 259 |
DYSPHAGIA |
1 |
0.0000 |
| 260 |
ANAEMIA |
2 |
0.0000 |
| 261 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 262 |
SYNCOPE |
1 |
0.0000 |
| 263 |
HYPOTENSION |
2 |
0.0000 |
| 264 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
2 |
0.0000 |
| 265 |
ILLNESS |
1 |
0.0000 |
| 266 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 267 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 268 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 269 |
CONSTIPATION |
2 |
0.0000 |
| 270 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 271 |
DEPRESSION |
2 |
0.0000 |
| 272 |
SEIZURE |
1 |
0.0000 |
| 273 |
CHILLS |
1 |
0.0000 |
| 274 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 275 |
HYPERHIDROSIS |
1 |
0.0000 |
| 276 |
DEHYDRATION |
1 |
0.0000 |
| 277 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 278 |
NEUTROPENIA |
1 |
0.0000 |
| 279 |
COUGH |
2 |
0.0000 |
| 280 |
ANXIETY |
2 |
0.0000 |
| 281 |
INFECTION |
1 |
0.0000 |
| 282 |
OFF LABEL USE |
6 |
0.0000 |
| 283 |
MALAISE |
3 |
0.0000 |
| 284 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 285 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 286 |
COVID-19 |
1 |
0.0000 |
| 287 |
SOMNOLENCE |
1 |
0.0000 |
| 288 |
ERYTHEMA |
1 |
0.0000 |
| 289 |
HYPERTENSION |
1 |
0.0000 |
| 290 |
DECREASED APPETITE |
1 |
0.0000 |
| 291 |
BACK PAIN |
1 |
0.0000 |
| 292 |
DIZZINESS |
2 |
0.0000 |
| 293 |
WEIGHT DECREASED |
1 |
0.0000 |
| 294 |
FALL |
1 |
0.0000 |
| 295 |
ASTHENIA |
1 |
0.0000 |
| 296 |
DEATH |
2 |
0.0000 |
| 297 |
PAIN |
1 |
0.0000 |
| 298 |
HEADACHE |
1 |
0.0000 |
| 299 |
FATIGUE |
1 |
0.0000 |